| Unadjusted HR (95% CI) | Unadjusted p-value | Adjusted HR (95% CI) | Adjusted p-value |
---|---|---|---|---|
Covariate | ||||
 Univariate | ||||
  Location of metastasis | 0.94 (0.35, 2.56) | 0.91 | 1.01 (0.41, 2.47) | 0.98 |
  Tumor size ≤2 cm | 0.26 (0.11, 0.59) | 0.001 | 0.25 (0.12, 0.54) | < 0.001 |
  Histologya | 1.70 (0.40, 7.25) | 0.47 | 1.77 (0.45, 6.95) | 0.41 |
  Surgical resection | 1.92 (0.57, 6.46) | 0.29 | 1.71 (0.55, 5.35) | 0.35 |
  SF vs HF-SRS | 1.07 (0.44, 2.61) | 0.88 | 0.81 (0.36, 1.83) | 0.61 |
  Concurrent systemic therapy | 0.55 (0.20, 1.48) | 0.24 | 0.49 (0.19, 1.26) | 0.14 |
  Prior WBRT | 1.72 (0.76, 3.90) | 0.20 | 1.41 (0.66, 3.02) | 0.37 |
 Multivariate | ||||
  SF- vs HF-SRS | 0.90 (0.28, 2.87) | 0.86 | 0.96 (0.30, 3.03) | 0.94 |
  Tumor size ≤2 cm | 0.20 (0.07, 0.57) | 0.003 | 0.21 (0.07, 0.58) | 0.003 |
  Prior WBRT | 1.35 (0.45, 4.03) | 0.59 | 1.13 (0.35, 3.59) | 0.84 |